Nicoleta Stoicea

Nicoleta Stoicea, MD, PhD, currently serves as Medical Director at Evolution Research Group since June 2024 and as Medical Director of Clinical Development at Solid Biosciences since November 2022. Previously, Nicoleta held the position of Assistant Professor of Practice at The Ohio State University College of Pharmacy from March 2020 to April 2023 and served as Medical Director of CNS Gene Therapy at Asklepios BioPharmaceutical from July 2021 to November 2022. Early career experiences include Research Program Director at Summa Health and Adjunct Assistant Professor at The Ohio State University Wexner Medical Center, focusing on clinical pharmacology and various phases of clinical trials. Additional roles include a physician position at Centre Hospitalier Pontivy in 2019 and a Graduate Teaching Associate role at The Ohio State University in 2006-2007. Nicoleta's educational background includes a Post Doctoral Fellowship in Neuroanesthesiology from The Ohio State University College of Medicine and MD, PhD degrees in Neurophysiology obtained from Universitatea de Medicină și Farmacie din Craiova.